JAK Inhibitors May Increase Risk of Shingles in Patients With Immune-Mediated Inflammatory Diseases
Drug Topics
OCTOBER 10, 2023
Patients with rheumatoid arthritis had a higher risk of shingles when treated once a day with 4 mg of baricitinib, 100 mg of peficitinib, or 30 mg of upadacitinib.
Let's personalize your content